BackSage Therapeutics Overview

Sage Therapeutics Net Tangible Assets

Track Sage Therapeutics's net tangible assets ($370M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$368.74M
↓ 41.29% YoYΔ $-259.32M vs prior year quarter

Peer average

Loading

Sage Therapeutics Net Tangible Assets History

Loading

Sage Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Sage Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sage Therapeutics (SAGE) FAQ

As of the most recent data (June 2025), SAGE shows a net tangible assets of $370M. That compares with $630M in the prior-year period — down 41.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SAGE's net tangible assets is now $370M (was $630M) — a 41.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sage Therapeutics is outperforming or lagging.

Tracking SAGE's net tangible assets over time shows whether Sage Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $370M That compares with $630M in the prior-year period — down 41.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Sage Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $370M) with ownership activity and broader fundamentals.

Sage Therapeutics's net tangible assets is $370M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.